Studies on the cytostatic and cytotoxic effects and mode of action of 8-nitro-7-hydroxycoumarin

Cancer Letters

Volumn 118, Issue 2, 1997, Pages 201-211

  Egan, Denise ^a   James, Paraic ^b   Cooke, Deirdre ^b   O'Kennedy, Richard ^b  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

8 Nitro 7 hydroxycoumarin; Chemotherapeutic agent; Coumarin; In vitro toxicity

Indexed keywords

8 NITRO 7 HYDROXYCOUMARIN; ANTINEOPLASTIC AGENT; COUMARIN DERIVATIVE; DNA; UNCLASSIFIED DRUG;

AMES TEST; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HL 60; CELL STRAIN K 562; CONTROLLED STUDY; CYTOSTASIS; DNA SYNTHESIS INHIBITION; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG PURIFICATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; CHO CELLS; CRICETINAE; DNA, NEOPLASM; DRUG RESISTANCE, MULTIPLE; GROWTH INHIBITORS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MUTAGENS; TUMOR CELLS, CULTURED; UMBELLIFERONES;

EID: 0030763338     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00331-5     Document Type: Article

References (35)

1. D. Egan, R. O'Kennedy, E. Moran, D. Cox, E. Prosser, R.D. Thornes, The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds, Drug Metab. Rev. 22 (5) (1990) 503-529.
2. S.W. Ebbinghaus, J.L. Mohler, M.E. Marshall, Renal cell carcinoma: the background, rationale and current development of coumarin (1,2-benzopyrone) as a potential therapeutic agent, in: R. O'Kennedy, R.D. Thornes (Eds.), Coumarins: Biology, Applications and Mode of Action, Wiley, Chichester, 1997, pp. 209-239.
3. L.M. Wattenburg, L.K.T. Lam, A.V. Fladmoe, Inhibition of chemical carcinogen-induced neoplasia by coumarin and α anglicolactone, Cancer Res. 39 (1979) 1651-1654.
4. G. Feur, L.A. Kellen, K. Kovacs, Suppression of 7,12-dimethylbenz(a)anthracene induced breast carcinoma by coumarin in the rat, Oncology 33 (1976) 35-39.
5. G.J. Zlabinger, Coumarins as an immunomodulator, in: R. O'Kennedy, R.D. Thornes (Eds.), Coumarins: Biology, Applications and Mode of Action, Wiley, Chichester, 1997, pp. 103-123.
6. A. Tseng, W.M. Lee, E.B, Jakobovits, E. Kirslen, A. Hakam, J. Mclick, K. Bukj, E. Kun, Prevention of tumourigenesis of oncogene-transformed rat fibroblasts with DNA site inhibitors of poly(ADP-ribose)polymerase, Proc. Natl. Acad. Sci. USA 84 (1987) 1107-1111.
7. D. Conley, M.E. Marshall, Effects of coumarin on human tumour cell growth and cell cycle in vitro, Proc. Am. Assoc. Cancer Res. 28 (1987) 63.
8. C.D. Zippe, E.T. Henry, W.D.N. Heston, W.R. Fair, Interaction of coumarin metabolites and immune modulators on human prostatic carcinoma cell lines, Proc. Am. Assoc. Cancer Res. 31 (1287) (1990) 217.
9. M.E. Marshall, S. Albainy-Jenei, A. Umerani, Q. Zhao, Direct cytotoxic effects of coumarin and 7-hydroxycoumarin on human malignant cell lines in vitro, J. Irish Colleges Phys. Surg. 22(2, Suppl. 1) (1993) 71.
10. E. Moran, E. Prosser, R. O'Kennedy, R.D. Thornes, The effects of coumarin and 7-hydroxycoumarin on the growth of human tumour cell lines, J. Irish Colleges Phys. Surg, 22 (2, Suppl. 1) (1993) 41-43.
11. C.P. Siegers, H.C. Bostelmann, Effects of coumarin on cell lines, J. Irish Colleges Phys. Surg. 22 (2, Suppl. 1) (1993) 47-48.
12. P.L. Triozzi, F. Vicstein, J. Ailabouni, R. Fertel, J.J. Rinehart, Effects of coumarins on interleukin-2 (IL-2) activity, Proc. Am. Assoc. Cancer Res. 31 (1990) 277.
13. M. Maxwell, S.P. Naber, H.J. Wolf, T. Galantopoulos, E.T. Hedley-Whyte, P.M. Black, N.H. Antoniades, Coexpression of platelet derived growth factor (PDGF) and PDGF-receptor genes by primary astrocytomas may contribute to their development, J. Clin. Invest. 86 (1990) 131-140.
14. B. Seliger, 7-Hydroxycoumarin mediated induction of differentiation of human malignant glioblastoma cells, J. Irish Colleges Phys. Surg. 22 (2, Suppl. 1) (1993) 44-46.
15. M. Najam, H. Shima, S. Aonuma, H. Nakagama, M. Nagao, T. Sulimura, Deletion of transfected oncogenes from NIH 3T3 transformants by inhibitors of poly(ADPribose)poly-merase, Proc. Natl. Acad. Sci. USA 85 (1986) 9066-9070.
16. K.S. Zänker, F. Harrns, U. Vogt, Influence of 7-OHC on oncogene expression (C-myc and Ha-ras), growth rate and phenotype of chinese hamster ovary carcinoma (DUKX) and rat mammary adenocarcinoma (RBA) cells, Proc. Am. Assoc. Cancer Res. 32 (1991) 402.
17. F. Rosskopf, J. Kraus, G. Franz, Immunological and antitumour effects of coumarin and some derivatives, Pharmazie 47 (2)(1992) 139-142.
18. A. Banerji, G. Nandi, Metal reagents in organic reactions: Part V reactions of coumarins with thallium 111 salts, Hetrocycles 26 (5) (1987) 1221-1226.
19. T. Mosmann, Rapid colourimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods 65 (1983) 55-63.
20. S.J. Martin, S.V. Lennon, A.M. Bonham, T.G. Cotter, Induction of apoptosis (programmed cell death) in human leukaemic HL-60 cells by inhibition of RNA or protein synthesis, J. Immunol. 145 (6) (1990) 1859-1867.
21. E.M. McDowell, B.S. Trump, Histologic fixatives suitable for light and electron microscope, Ac. Pathol. Lab. Med. 100 (1976) 405-414.
22. D.M. Maron, B.N. Ames, Revised methods for the Salmonella mutagenicity tests, Mutat. Res. 113 (1983) 173-215.
23. 1H-NMR, IR, MS, UV/Vis. Laboratory Practice, Springer, New York, 1983.
24. T.G. Cotter, Induction of apoptosis in cells of the immune system by cytotoxic stimuli, Sem. Immunol. 4 (6) (1992) 399-405.
25. A.H. Wyllie, Apoptosis, Immunology 1 (1988) 192-196.
26. S. Sen, M. D'Incalci, Apoptosis: biochemical events and relevance to cancer therapy, FEBS Lett. 307 (1) (1992) 122-127.
27. M. Clynes, A. Redmond, M. Heenan, Recent developments in research on multiple drug-resistance in cancer cells, Cancer J. 3 (1990) 34-39.
28. N. Kartner, D. Evemder-Porelle, G. Bradley, V. Ling, Detection of P-glycoprotein in multi-drug resistant cell lines by monoclonal antibodies, Nature 316 (1985) 320-323.
29. HRC report, Ames metabolic activation test to assess the potential effects of Venalot, No. SCB 10/78294.
30. W. Stemer, W.D. Korn, Micronucleus test on Venalot in mice. IBR Forschungs GmbH, 6-1-252-81, 1981.
31. K.S. Zänker, The mode of entry of coumarin into cells and its effects on cell-cell communication and migration, in: R. O'Kennedy, R.D. Thornes (Eds.), Coumarins: Biology, Applications and Mode of Action, Wiley, Chichester, 1997, pp. 125-141.
32. H.C. Huang, M.W. Lai, H.R. Wang, Y.-L. Chung, L.M. Hsieh, C.-C. Chen, Antiproliferative effect of esculetin on vascular smooth muscle cells: possible roles of signal transduction pathways, Eur. J. Pharmacol. 237 (1993) 39-44.
33. B. Seliger, H. Pettersson, Mechanism of action of 7-hydroxycoumarin on human malignant glioblastoma cell lines. Proc. Int. Soc. Coumarin Invest. Newsletter, 1994.
34. R. Derynck, D.V. Goeddel, A. Ullrich, J.U. Gutterman, R.D. Williams, T.S. Bringman, W.H. Berger, Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumours, Cancer Res. 47 (1987) 707-712.
35. A. Levitski, Signal transduction therapy: a novel approach to disease management, Eur. J. Biochem. 226 (1994) 1-13.